Antileishmanial Efficacy and Pharmacokinetics of DB766-Azole Combinations

Given the limitations of current antileishmanial drugs and the utility of oral combination therapy for other infections, developing an oral combination against visceral leishmaniasis should be a high priority. In vitro combination studies with DB766 and antifungal azoles against intracellular Leishm...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Antimicrob Agents Chemother
Autori principali: Joice, April C., Yang, Sihyung, Farahat, Abdelbasset A., Meeds, Heidi, Feng, Mei, Li, Junan, Boykin, David W., Wang, Michael Zhuo, Werbovetz, Karl A.
Natura: Artigo
Lingua:Inglês
Pubblicazione: American Society for Microbiology 2017
Soggetti:
Experimental Therapeutics
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC5740383/
https://ncbi.nlm.nih.gov/pubmed/29061761
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/AAC.01129-17
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi